XOMA Royalty (XOMA) Long-Term Investments (2018 - 2022)
XOMA Royalty's (XOMA) quarterly Long-Term Investments came in at $500000.0 in Q1 2022, down 37.5% year-on-year from $800000.0 in Q1 2021, and down 37.5% quarter-over-quarter from $800000.0 in Q4 2021.
XOMA Royalty (XOMA) Long-Term Investments (2018 - 2022) Analysis & Trends
XOMA Royalty has disclosed Long-Term Investments across 5 years of filings, most recently posting $500000.0 for Q1 2022.
- Long-Term Investments for Q1 2022 came in at $500000.0, down 37.5% year-over-year; the trailing twelve-month figure through Mar 2022 was $500000.0 (down 37.5% YoY), and the FY2021 annual result was $800000.0, down 52.75% from the prior year.
- Long-Term Investments came in at $500000.0 for Q1 2022 at XOMA Royalty, down from $800000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $2.6 million in Q3 2020 to a low of $347000.0 in Q3 2018.
- The 5-year median for Long-Term Investments is $800000.0 (2021), against an average of $993437.5.
- Across the five-year window, Long-Term Investments plunged 63.14% in 2020 and jumped 333.15% in 2021, its largest moves.
- XOMA Royalty's Long-Term Investments stood at $392000.0 in 2018, then jumped by 73.72% to $681000.0 in 2019, then soared by 148.6% to $1.7 million in 2020, then sank by 52.75% to $800000.0 in 2021, then plunged by 37.5% to $500000.0 in 2022.
- The last three Long-Term Investments figures came in at $500000.0 (Q1 2022), $800000.0 (Q4 2021), and $1.2 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 2.30 Mn |
| Mar 31, 2021 | 800,000.00 |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | 2.57 Mn |
| Jun 30, 2020 | 531,000.00 |
| Mar 31, 2020 | 408,000.00 |
| Dec 31, 2019 | 681,000.00 |
| Sep 30, 2019 | 873,000.00 |
| Jun 30, 2019 | 1.14 Mn |
| Mar 31, 2019 | 1.11 Mn |
| Dec 31, 2018 | 392,000.00 |
| Sep 30, 2018 | 347,000.00 |
| Jun 30, 2018 | 553,000.00 |